Stockscreener 앱 받기
3.37
1.20%
0.04
시장 영업 전:
3.39
0.02
+0.59%
전일 마감가:
$3.33
열려 있는:
$3.33
하루 거래량:
2.06M
Relative Volume:
0.88
시가총액:
$548.23M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
84.25
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
+3.37%
1개월 성능:
-3.71%
6개월 성능:
+369.88%
1년 성능:
-23.93%
1일 변동 폭
$3.29
$3.38
1주일 범위
$3.11
$3.385
52주 변동 폭
$0.5271
$4.775
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
IRWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
3.37 | 541.72M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Why is Ironwood (IRWD) up 24.9% since last earnings report? - MSN
Ironwood Pharmaceuticals expresses gratitude and drives GI health progress - Traders Union
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 4.8%Still a Buy? - MarketBeat
Ironwood Pharma (NASDAQ:IRWD) Nasdaq composite Biotech Watch - Kalkine Media
Ironwood Pharmaceuticals (NASDAQ:IRWD) Share Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Ironwood Pharmaceuticals' VectivBio Settles Ferring Lawsuit Through License Amendment - marketscreener.com
Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property - The Business Journals
Ironwood gains after settling Ferring lawsuit (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals amends license deal with Ferring, settles litigation By Investing.com - Investing.com UK
Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) added to S&P Biotechnology Select Industry Index - marketscreener.com
How Ironwood Pharmaceuticals Inc. (I76) stock reacts to Fed tighteningOil Prices & Free Accurate Trade Setup Notifications - Улправда
Geopolitics Watch: Why Ironwood Pharmaceuticals Inc. stock is rated strong buyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда
Why Ironwood Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Update & High Accuracy Trade Signal Alerts - Улправда
Ironwood Pharmaceuticals Earnings Notes - Trefis
Published on: 2025-12-19 06:52:33 - Улправда
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7%Here's Why - MarketBeat
What drives Ironwood Pharmaceuticals Inc stock priceMarket Entry Points & High Yield Portfolio Growth - earlytimes.in
Ironwood Pharmaceuticals (IRWD) director and 10% owner reports new share grant - Stock Titan
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Ironwood Pharmaceuticals announces workforce reduction - MSN
Ironwood Pharma Board Member Resigns for New Role - MSN
Ironwood Pharma drops 7% as FY 2025 revenue guidance below consensus - MSN
Armistice Capital LLC Acquires 2,450,000 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? - sharewise.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6%What's Next? - MarketBeat
Ironwood Pharmaceuticals (IRWD) price target increased by 38.89% to 2.55 - MSN
Ironwood Pharma’s LINZESS® Price Set by HHS - MSN
Can Ironwood Pharmaceuticals Stock Recover If Markets Fall? - Trefis
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 38.89% to 2.55 - Nasdaq
Can Ironwood Pharmaceuticals Stock Hold Up When Markets Turn? - Trefis
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 5%Time to Sell? - MarketBeat
Is Ironwood Pharmaceuticals Inc. (I76) stock cheap by valuation metricsOptions Play & Scalable Portfolio Growth Ideas - Newser
Can Ironwood Pharmaceuticals Inc. stock sustain institutional interestProfit Target & Fast Gaining Stock Strategy Reports - Newser
Zacks Research Analysts Increase Earnings Estimates for IRWD - MarketBeat
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
How dovish Fed policy supports Ironwood Pharmaceuticals Inc. (I76) stockRecession Risk & Weekly High Return Forecasts - Newser
Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News
IRWD SEC FilingsIronwood 10-K, 10-Q, 8-K Forms - Stock Titan
Is Ironwood Pharmaceuticals, Inc. overvalued or undervalued? - Markets Mojo
How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflationLayoff News & Fast Momentum Entry Tips - Newser
Volume Summary: Can Ironwood Pharmaceuticals Inc stock deliver 10 annual returns2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 4.5% HigherTime to Buy? - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Universal Beteiligungs und Servicegesellschaft mbH Buys 108,822 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? - Yahoo Finance
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations - Finviz
Ironwood Pharmaceuticals chief legal officer sells shares worth $68,530 - MSN
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? - sharewise.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap UpHere's Why - MarketBeat
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous H1 2025 (IRWD) - Seeking Alpha
Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On WednesdayArrowhead Pharma (NASDAQ:ARWR), Duolingo (NASDAQ:DUOL) - Benzinga
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.30%
0.62%
자본화:
|
볼륨(24시간):